In the USA Omega-3 market is shifting toward pharma-grade formulations, driven by rising cardiovascular prescriptions. Leading players like KD Pharma, DSM, and BASF are expanding high-purity EPA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback